Fondaparinux bør ikke anvendes til patienter med alvorligt nedsat nyrefunktion (kreatininclearance Læ
In this subgroup, after an initial 10 mg daily dose, a reduction of the daily dose to 7.5 mg may be considered, based on pharmacokinetic modelling (see section 4.4).